Back to top
more

DexCom (DXCM)

(Delayed Data from NSDQ)

$110.91 USD

110.91
1,353,061

-1.58 (-1.40%)

Updated Jul 3, 2024 01:00 PM ET

After-Market: $110.96 +0.05 (0.05%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 38% (155 out of 249)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

Research for DXCM

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

0 items in cart

DexCom, Inc. [DXCM]

Reports for Purchase

Showing records 181 - 200 ( 413 total )

Company: DexCom, Inc.

Industry: Medical - Instruments

Record: 181

08/17/2016

Industry Report

Pages: 23

HEALTHCARE - 2016 PacGrow Healthcare Conference Day 1

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 75.00

Research Provided by a Third Party

Company: DexCom, Inc.

Industry: Medical - Instruments

Record: 182

08/17/2016

Industry Report

Pages: 23

Biotechnology/Biopharmaceuticals - 2016 PacGrow Healthcare Conference Day 1

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 75.00

Research Provided by a Third Party

Company: DexCom, Inc.

Industry: Medical - Instruments

Record: 183

08/17/2016

Industry Report

Pages: 17

Medical Devices - Day 1: Key Takeaways from the PacGrow Healthcare Conference

Provider: WEDBUSH SECURITIES INC.

Price: 50.00

Research Provided by a Third Party

Company: DexCom, Inc.

Industry: Medical - Instruments

Record: 184

08/04/2016

Company Report

Pages: 8

Price: 24.95

Company: DexCom, Inc.

Industry: Medical - Instruments

Record: 185

08/03/2016

Company Report

Pages: 10

Q2 results mixed, - law of large numbers - kicking in? Maintain SELL

Provider: Feltl & Company

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Company: DexCom, Inc.

Industry: Medical - Instruments

Record: 186

08/03/2016

Company Report

Pages: 7

Fundamentals Solid with Sales Topping Expectations, But Offset by Lower GM; Maintain OUTPERFORM

Provider: WEDBUSH SECURITIES INC.

Price: 25.00

Research Provided by a Third Party

Company: DexCom, Inc.

Industry: Medical - Instruments

Record: 187

07/28/2016

Company Report

Pages: 8

CGM Project: Historical survey of 2,166 CGM users (2007 - present)

Provider: Feltl & Company

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Company: DexCom, Inc.

Industry: Medical - Instruments

Record: 188

07/28/2016

Company Report

Pages: 8

CGM Project: Historical analysis of 2,166 CGM users (2007 - present)

Provider: Feltl & Company

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Company: DexCom, Inc.

Industry: Medical - Instruments

Record: 189

07/22/2016

Company Report

Pages: 6

Post Panel Conference Call Update; Management Acknowledges that Non-Adjunctive Claim is a "Big Deal";Reiterate OUTPERFORM

Provider: WEDBUSH SECURITIES INC.

Price: 25.00

Research Provided by a Third Party

Company: DexCom, Inc.

Industry: Medical - Instruments

Record: 190

07/22/2016

Company Report

Pages: 7

FDA Panel votes to recommend ''''dosing'''' approval

Provider: Feltl & Company

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Company: DexCom, Inc.

Industry: Medical - Instruments

Record: 191

07/22/2016

Daily Note

Pages: 4

Dexcom with OUTPERFORM: Despite Contentious Panel, Vote was Overwhelming in Favor; Reiterate OUTPERFORM

Provider: WEDBUSH SECURITIES INC.

Price: 10.00

Research Provided by a Third Party

Company: DexCom, Inc.

Industry: Medical - Instruments

Record: 192

07/21/2016

Daily Note

Pages: 5

Initial Thoughts on Part 1 of Dexcom''s FDA Advisory Panel.

Provider: WEDBUSH SECURITIES INC.

Price: 10.00

Research Provided by a Third Party

Company: DexCom, Inc.

Industry: Medical - Instruments

Record: 193

07/20/2016

Daily Note

Pages: 5

Dexcom with OUTPERFORM: A Potentially Contentious FDA Panel Meeting Lies Ahead, But We Still Expect A Favorable Outcome

Provider: WEDBUSH SECURITIES INC.

Price: 10.00

Research Provided by a Third Party

Company: DexCom, Inc.

Industry: Medical - Instruments

Record: 194

07/19/2016

Company Report

Pages: 8

Price: 24.95

Company: DexCom, Inc.

Industry: Medical - Instruments

Record: 195

07/15/2016

Daily Note

Pages: 41

Medical Devices: 2Q16 MedTech Preview: Stable Trends and Healthy Underlying Fundamentals

Provider: WEDBUSH SECURITIES INC.

Price: 100.00

Research Provided by a Third Party

Company: DexCom, Inc.

Industry: Medical - Instruments

Record: 196

07/10/2016

Industry Report

Pages: 6

Diabetes: Artificial Pancreas Workshop Provides Insights On the Future of the Diabetes Market

Provider: WEDBUSH SECURITIES INC.

Price: 25.00

Research Provided by a Third Party

Company: DexCom, Inc.

Industry: Medical - Instruments

Record: 197

06/28/2016

Company Report

Pages: 8

Price: 24.95

Company: DexCom, Inc.

Industry: Medical - Instruments

Record: 198

06/21/2016

Company Report

Pages: 8

Price: 24.95

Company: DexCom, Inc.

Industry: Medical - Instruments

Record: 199

06/15/2016

Daily Note

Pages: 9

American Diabetes Association Meeting Suggests a Diabetes Technology Renaissance Is Coming; Reiterate OUTPERFORM

Provider: WEDBUSH SECURITIES INC.

Price: 25.00

Research Provided by a Third Party

Company: DexCom, Inc.

Industry: Medical - Instruments

Record: 200

06/05/2016

Industry Report

Pages: 5

Diabetes Technology Update: Regulatory Environment for AP Programs Less Onerous; MDT''s 670G and CGM Technology Improve; DXCM Seeks Replacement Claim

Provider: WEDBUSH SECURITIES INC.

Price: 10.00

Research Provided by a Third Party